JPS4829758A - - Google Patents

Info

Publication number
JPS4829758A
JPS4829758A JP46063722A JP6372271A JPS4829758A JP S4829758 A JPS4829758 A JP S4829758A JP 46063722 A JP46063722 A JP 46063722A JP 6372271 A JP6372271 A JP 6372271A JP S4829758 A JPS4829758 A JP S4829758A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP46063722A
Other languages
Japanese (ja)
Other versions
JPS5614663B2 (en:Method
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP6372271A priority Critical patent/JPS5614663B2/ja
Priority to US281804A priority patent/US3929765A/en
Priority to FR7229858A priority patent/FR2150816B1/fr
Priority to DE2241097A priority patent/DE2241097A1/de
Priority to GB3893772A priority patent/GB1393449A/en
Publication of JPS4829758A publication Critical patent/JPS4829758A/ja
Publication of JPS5614663B2 publication Critical patent/JPS5614663B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP6372271A 1971-08-21 1971-08-21 Expired JPS5614663B2 (en:Method)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP6372271A JPS5614663B2 (en:Method) 1971-08-21 1971-08-21
US281804A US3929765A (en) 1971-08-21 1972-08-18 Novel 3-substituted-aminoazetidine derivatives and process for preparation thereof
FR7229858A FR2150816B1 (en:Method) 1971-08-21 1972-08-21
DE2241097A DE2241097A1 (de) 1971-08-21 1972-08-21 Neue 3-substituierte-aminoazetidinderivate und verfahren zu ihrer herstellung
GB3893772A GB1393449A (en) 1971-08-21 1972-08-21 3-aminoazetidines and methods for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6372271A JPS5614663B2 (en:Method) 1971-08-21 1971-08-21

Publications (2)

Publication Number Publication Date
JPS4829758A true JPS4829758A (en:Method) 1973-04-19
JPS5614663B2 JPS5614663B2 (en:Method) 1981-04-06

Family

ID=13237559

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6372271A Expired JPS5614663B2 (en:Method) 1971-08-21 1971-08-21

Country Status (5)

Country Link
US (1) US3929765A (en:Method)
JP (1) JPS5614663B2 (en:Method)
DE (1) DE2241097A1 (en:Method)
FR (1) FR2150816B1 (en:Method)
GB (1) GB1393449A (en:Method)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888773A (en) * 1972-04-27 1975-06-10 Mobil Oil Corp Nitrogen compounds linked to a heterocyclic ring as multifunctional additives in fuel and lubricant compositions
US4120968A (en) * 1975-07-31 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic alkylaminocyclobutenediones
US4727152A (en) * 1982-09-30 1988-02-23 A. H. Robins Company, Inc. Intermediates useful in the preparation of fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof
FR2560194B1 (fr) * 1984-02-27 1987-08-07 Midy Spa 3-aminoazetidine, ses sels, procede pour leur preparation et intermediaires de synthese
FR2649100B1 (fr) * 1989-06-29 1994-03-04 Laboratorios Dr Esteve Sa Nouvelles azetidines, leur preparation et leur application comme intermediaires pour la preparation de composes avec activite antimicrobienne
AU1089599A (en) * 1997-10-15 1999-05-03 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
WO2000063168A1 (en) * 1999-04-16 2000-10-26 Coelacanth Chemical Corporation Synthesis of azetidine derivatives
EP1976828B1 (en) 2005-12-29 2016-12-21 Celtaxsys, Inc. Diamine derivatives as inhibitors of leukotriene a4 hydrolase
KR101426408B1 (ko) * 2013-02-19 2014-08-07 한국과학기술연구원 4각 고리 질소 화합물, 이를 포함하는 우울증, 정신 질환, 조루증, 또는 신경병증성 통증의 예방 또는 치료용 약학 조성물, 및 상기 약학 조성물을 포함하는 제제
ES2864862T3 (es) 2013-03-12 2021-10-14 Celltaxis Llc Métodos de inhibición de la leucotrieno A4 hidrolasa
MX2015011677A (es) * 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
MX2015011678A (es) 2013-03-14 2016-07-08 Celtaxsys Inc Inhibidores de leucotrieno a4 hidrolasa.
US10898484B2 (en) 2018-05-31 2021-01-26 Celltaxis, Llc Method of reducing pulmonary exacerbations in respiratory disease patients

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3481920A (en) * 1965-10-22 1969-12-02 Lilly Co Eli Azetidinones

Also Published As

Publication number Publication date
JPS5614663B2 (en:Method) 1981-04-06
FR2150816A1 (en:Method) 1973-04-13
US3929765A (en) 1975-12-30
DE2241097A1 (de) 1973-03-08
FR2150816B1 (en:Method) 1976-07-02
GB1393449A (en) 1975-05-07

Similar Documents

Publication Publication Date Title
FR2150816B1 (en:Method)
AU2691671A (en:Method)
AU2952271A (en:Method)
AU2742671A (en:Method)
AU2564071A (en:Method)
AU3005371A (en:Method)
AU2941471A (en:Method)
AU2726271A (en:Method)
AU2485671A (en:Method)
AU1109576A (en:Method)
AR202997Q (en:Method)
AU2588771A (en:Method)
AU2486471A (en:Method)
AU2669471A (en:Method)
AU2837671A (en:Method)
AU3265571A (en:Method)
AU2706571A (en:Method)
AU2836771A (en:Method)
AU2399971A (en:Method)
AU2930871A (en:Method)
AU2940971A (en:Method)
AU2503871A (en:Method)
AU2740271A (en:Method)
AU2577671A (en:Method)
AU2724971A (en:Method)